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Extremely low-frequency electromagnetic fields (ELF-EMFs) can interact with biological systems. Although they are successfully
used as therapeutic agents in physiatrics and rehabilitative practice, they might represent environmental pollutants and pose a risk
to human health. Due to the lack of evidence of their mechanism of action, the effects of ELF-EMFs on differentiation processes in
skeletal muscle were investigated. C2C12 myoblasts were exposed to ELF-EMFs generated by a solenoid. The effects of ELF-EMFs
on cell viability and on growth and differentiation rates were studied using colorimetric and vital dye assays, cytomorphology, and
molecular analysis of MyoD andmyogenin expression, respectively.The establishment of functional gap junctions was investigated
analyzing connexin 43 expression levels and measuring cell permeability, using microinjection/dye-transfer assays.The ELF-EMFs
did not affect C2C12 myoblast viability or proliferation rate. Conversely, at ELF-EMF intensity in the mT range, the myogenic
process was accelerated, through increased expression ofMyoD,myogenin, and connexin 43.The increase in gap-junction function
suggests promoting cell fusion and myotube differentiation.These data provide the first evidence of the mechanism through which
ELF-EMFs may provide therapeutic benefits and can resolve, at least in part, some conditions of muscle dysfunction.
1. Introduction
Modern industrial society produces considerable levels of
electromagnetic fields (EMFs), caused by widespread use
of electric-power-generating facilities that deliver energy to
domestic and industrial appliances. These EMFs are charac-
terized by frequencies of 50Hz to 60Hz and are part of the
extremely low-frequency (ELF) electromagnetic spectrum
[1].
Even if ELF-EMFs are nonionizing radiation, they can
interact with biological matter [2]. Since the 1980s, chronic
exposure to ELF-EMFs has been implicated in carcinogenesis
[3, 4], even if epidemiological studies have not provided con-
clusive or statistically adequate data.This hasmainly been due
to confounding by variable exposure times and misclassifica-
tion selection bias [5, 6].
On the other hand, ELF-EMF-based therapies are com-
monly used in differentmedical fields, such as physiatrics and
patient rehabilitation [7–9], with apparent beneficial effects.
However, at present, the cellular mechanism(s) behind these
effects remains unclear. Consequently, experimental inves-
tigations addressing how, and to what extent, ELF-EMFs
influence living matter become urgent.
Our studies have been specifically designed to provide
new insight into the mechanism(s) responsible for the bio-
logical effects of ELF-EMFs on skeletal muscle.We previously
described the effects of ELF-EMFs on the C2C12 myoblast
cell line [10], a well-known in vitro model of skeletal muscle
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phenotype [11].We demonstrated that ELF-EMFs affect intra-
cellular reactive oxygen species production, mitochondrial
membrane potential, and Ca2+ handling, which have been
shown to be all patterns strictly dependent on the cell differ-
entiation stage in muscle tissue [12]. Such ELF-EMF-induced
changes in mitochondrial activity and Ca2+ homeostasis
support the hypothesis that exposure to ELF-EMFs can effec-
tively modulate regulation of the myogenesis in C2C12 myo-
blasts.
Skeletal myogenesis is required for growth, maintenance,
and repair of injured muscle [13]. It is a multistep develop-
mental process determined by a complex cascade of events
involving development and differentiation ofmyoblasts, their
fusion to form primary and secondary myotubes, and their
subsequent maturation into fully developed adult muscle
fibers [14, 15].
In recent years, several studies have led to significant
improvements in the definition and understanding of the
phases of the commitment and differentiation processes of
skeletal muscle cells [15–19]. Many in vitro studies have
focused on the role of gap-junction-mediated intercellular
communication (GJIC) in specific and critical stages of myo-
genesis [20–23]. It has been hypothesized that GJIC might be
involved in the onset of the differentiation process, to coordi-
nate the myoblasts that are committed to differentiate, thus
promoting their alignment and fusion, and, consequently,
the intercellular diffusion of critical signaling molecules
(i.e., Ca2+, inositol 1,4,5-trisphosphate, and adenosine 5󸀠-
triphosphate) [21, 24, 25]. The evidence that short exposure
to ELF-EMFs has effects on both C2C12 myoblasts and myo-
tubes through modulation of their redox status and Ca2+
handling [10] also suggests a possible involvement of GJIC
and, as a consequence, of long-term biological processes, like
myogenesis [26].
To further clarify the mechanism(s) responsible for ELF-
EMF-induced effects on myogenesis, in the present study we
exposed differentiating C2C12 myoblasts to ELF-EMFs, and,
in particular, we monitored their gap-junction permeability,
which is considered to be a crucial function for myotube
formation during progression through myogenesis.
2. Materials and Methods
2.1. Equipment. A horizontal solenoid (Oersted Technology
Corporation) was designed and built to deliver variable,
homogeneous, sine-wave alternating-current magnetic fields
at 50Hz frequency and with intensities from 0.1mT to 1.0mT
(±2%).This was used to expose large numbers of cells to ELF-
EMFs simultaneously [10, 27, 28]. The horizontal cylindrical
solenoid presents the following features: length, 340mm;
diameter, 113mm; number of wire turns, 144; resistance at
20∘C (Ω), 0.3; this device was mounted on a nonmagnetic
supporting base and powered using a power supply (CW-
801P; Elgar Electronics). In particular, the power supply
was operated in its “closed-loop current mode”: the output
current and the generated magnetic field were consequently
regulated against thermal and physical variations/drift of the
coil. The final measured value of the solenoid coil constant
was 4.830 Gauss/Amp.The solenoid was used in a cell culture
incubator (5% CO
2
, 37∘C; HERAcell, Kendro Laboratory
Products GmbH, Hanau, Germany) for long periods, provid-
ing continuous exposure of the cells (1–7 days). During these
treatments, any temperature increase in the incubator due to
the solenoid was negligible. The tested value of background
electromagnetic fields was less than 1𝜇T (50Hz). In particu-
lar it was in the order of 0.7 𝜇T (50Hz) in the incubator and
outside the switched on solenoid and of 100 nT (50Hz) out-
side or inside the switched off solenoid placed in the incuba-
tor. Moreover, in laboratory areas between incubators, work-
tops, and cell cultures hood, electromagnetic fields measured
40–140 nT (50Hz).The EMFmeters used to measure the val-
ues of electromagnetic fields are F.W.BELL Tesla meters mod.
4190 (measuring range: 0.01–200𝜇T, resolution: 0.01 𝜇T) and
mod. 6010 equipped with an axial probe mod. HAD61-2508-
05T (measuring range: 0.3–300mT, minimum resolution:
0.01mT) both from Sypris Test & Measurement (Orlando,
FL). The cells were cultured in plastic dishes that are trans-
parent to the ELF magnetic field.
2.2. Chemicals and Materials. Unless otherwise indicated,
the cell culture media, sera, and antibiotics were from Ther-
mofisher (Monza, Italy), the cell culture plasticware was from
Becton Dickinson Falcon (Sacco Srl, Cadorago, Italy), and
the reagents and standards were from Sigma-Aldrich (Milan,
Italy).
2.3. Cell Culture. Undifferentiated C2C12 cells (myoblasts;
CRL 1772; American Type Culture Collection, Manassas,
VA, USA) were maintained routinely in growth medium
(Dulbecco’s modified Eagle’s medium, 20% fetal bovine
serum, 4mML-glutamine, 100 IU/mL penicillin, and
100 𝜇g/mL streptomycin). The differentiated phenotype of
these C2C12 myoblasts (i.e., myotubes) was obtained by
culturing these cells in differentiation medium (Dulbecco’s
modified Eagle’s medium, 2% heat-inactivated horse serum,
4mML-glutamine, 100 IU/mL penicillin, and 100 𝜇g/mL
streptomycin) for 7 days to 10 days. Both undifferentiated and
differentiating C2C12 myoblasts were routinely maintained
at 37∘C in a humidified 5% CO
2
atmosphere.
2.4. Viability and Proliferation Assays. The analysis of cell
viability was performed using trypan blue exclusion tests and
cell growth using colorimetric assays based on the reduction
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT). Briefly, C2C12 myoblasts (4.0 × 103 cells/cm2)
were plated into 96-well plates (Corning-Costar, Milan, Italy)
in growth medium. At selected times with the absence and
presence of the ELF-EMF treatments, MTT was added to
each well to a final concentration of 0.5mg/mL. After 3 h at
37∘C, the plates were centrifuged at 500×g for 5min. The
supernatants were removed, and 200𝜇L dimethyl sulfoxide
was added to each well. After 30min at 37∘C, the absorbance
of each well was determined using a microplate reader (Spec-
traMAX 190), at 560 nm. The trypan blue exclusion assay
was performed by staining C2C12 myoblasts with a trypan
blue dye solution (0.5% in phosphate-buffered saline), and the
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stained cells were counted using a hemocytometer (Bu¨rker
chamber). Blue stained cells were considered nonviable.
2.5. Fusion Index. The extent of successful differentiation of
C2C12 myoblasts into myotubes was determined by mor-
phological analysis and Hoechst staining of the nuclei [29].
C2C12 myoblasts (4.0 × 103 cells/cm2) were seeded in growth
medium onto sterile coverslips (Ø, 12mm) in 24-well plates.
After 3 days, the growthmediumwas shifted to differentiation
medium, and the C2C12 myoblasts were induced to differen-
tiate for up to 7 days in the absence and presence of the ELF-
EMF treatments. At each time point, the cells were washed
twice with phosphate-buffered saline, fixed in 90% ethanol,
and stained with Hoechst solution. Images were acquired
using an inverted microscope (Olympus IX-70) equipped
with a digital camera (Camedia C-5050; Olympus). At least
20 fields were analyzed for each experimental condition. The
Fusion Index was quantified as the percentage of Hoechst-
stained nuclei located within multinucleated cells (with at
least two nuclei, as a result of myoblast fusion), based on the
total analyzed nuclei.
2.6. Western Blotting. C2C12 myoblasts (4.0 × 103 cells/cm2)
were seeded in growth medium into 100mm diameter Petri
dishes. After 3 days, the growth medium was shifted to
differentiation medium, and the cells were maintained in the
absence and presence of the ELF-EMF treatments. At each
experimental point, the cells were scraped, lysed, and col-
lected in sample buffer (62.5mM Tris-HCl, pH 6.8, 2% SDS,
10% glycerol, 0.1M dithiothreitol, and 0.002% bromophenol
blue). Protein concentrations were determined using the
protein assay kits (Bio-Rad DC; Bio-Rad, Segrate, Italy). The
whole cell extracts were separated using SDS-PAGE on 7.5%
or 12.5% (w/v) homogeneous slab gels (40 𝜇g protein/lane)
and then transferred onto polyvinylidene fluoride mem-
branes (Immobilon-P; Merck-Millipore, Vimodrone, Italy).
Equal loading of protein samples was monitored using Coo-
massie blue staining of identical gels run in parallel (0.25%
Coomassie blue solution; R 250/G 250 1 : 1; Bio-Rad). Red
Ponceau S (Sigma-Aldrich) staining of each membrane was
used to monitor the transfer efficiency.
The membranes were hybridized with a mouse mon-
oclonal anti-connexin 43 (cx43) antibody (dilution, 1 : 500;
Chemicon International Inc., Temecula, CA, USA), a rabbit
polyclonal anti-MyoD antibody (dilution, 1 : 500; Santa Cruz
Biotechnology Inc., SantaCruz, CA,USA), or amousemono-
clonal anti-myogenin antibody (dilution, 1 : 500; Santa Cruz
Biotechnology Inc.), followed by reaction with horseradish-
peroxidase-conjugated anti-mouse or anti-rabbit IgGs
(1 : 10,000; GE Healthcare, Cologno Monzese, Italy). The
membranes were then incubated with horseradish-peroxi-
dase conjugated anti-IgG, with the relevant proteins detected
using chemiluminescence kits (Pierce EuroClone S.p.A.,
Pero, Italy) and an image acquisition system (Uvitec, Cam-
bridge, UK). An anti-ERK1/2 antibody (1 : 2000 dilution;
Santa Cruz Biotechnology Inc.) was used as the loading
control.
2.7. Microinjection/Dye-Transfer Assay. The differentiating
C2C12 myoblasts were tested for their establishment of
functional gap junctions using a microinjection/dye-transfer
assay, following the protocol proposed by Mazzoleni et al.
[30]. Briefly, C2C12 myoblasts (4.0 × 103 cells/cm2) were
seeded in growth medium into 60mm diameter Petri dishes.
After 3 days, the growthmediumwas shifted to differentiation
medium, and the cell cultures weremaintained in the absence
and presence of the ELF-EMF treatments. For the dye-trans-
fer assay, single cells within a monolayer were microinjected
with a 10% (w/v) solution of the gap-junction-permeant flu-
orescent tracer lucifer yellow CH in 0.33M lithium chloride.
Microinjections were performed using glass capillary needles
(Clark Electromedical Instruments, Edenbridge, UK) pre-
pared in an automatic puller (Narishige, Tokyo, Japan). The
needles were driven using a micromanipulator (Narishige
5240) linked to a fluorescence microscope (Olympus IMT2-
SYFII). The fluorescent dye was injected into single cells
under nitrogen pressure, using a microinjector (Eppendorf,
Hamburg, Germany). Five minutes after the last injection,
the cells were fixed with 4% paraformaldehyde in phosphate-
buffered saline, and their dye-transfer was evaluated. The
extent of functional GJIC was quantified by counting the
number of fluorescent cells surrounding the microinjected
cells (i.e., the number of dye-coupled cells/injection). For the
precise quantification of functional GJIC in the cultures, at
least 25 independent microinjection trials/dish were carried
out in three separate dishes for each experimental point.
Functional GJIC is expressed as the means ± SEM.
Fluorescence and phase-contrast images of untreated
and ELF-EMF-treated monolayers were obtained using the
inverted fluorescence microscope (Olympus IMT2-SYFII)
equipped with a digital camera (Olympus OM-4 Ti reflex).
2.8. Statistical Analyses. Statistical analysis was performed
using the Prism 4 software forWindows (GraphPad Software
Inc., San Diego, CA, USA). Unless otherwise indicated, all of
the data are expressed as means ± SD or ± SEM, as specified
in the figure legends. Comparisons were made using 𝑡-tests.
3. Results
3.1. Effects of ELF-EMF Exposure on C2C12 Myoblast Prolifer-
ation and Differentiation. The effects of ELF-EMF exposure
on the C2C12myoblast growth rate and viability were studied
using a colorimetric assay and vital dye staining, respectively.
These analyses were performed on undifferentiated C2C12
myoblast cultures exposed for up to 7 days to ELF-EMF
treatments at different field intensities (0.1, 0.5, and 1.0mT).
As shown in Figure 1, exposure of the C2C12 myoblasts to
these ELF-EMFs did not significantly affect either cell prolif-
eration rates or viability; indeed, the numbers of nonviable
cells did not differ between the ELF-EMF-treated C2C12
myoblast cultures and their corresponding untreated controls
and remained from 10% to 15% of the total cells.
The effect of ELF-EMF exposure on the myogenesis pro-
cess of the C2C12 myoblasts was explored using morphologi-
cal analysis and quantification of the expression ofMyoD and
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Figure 1: Effects of ELF-EMF treatments on C2C12 myoblast proliferation. Cell proliferation curves derived from MTT colorimetric assays
performed on C2C12 myoblasts in the absence (Ctr) and presence of ELF-EMF treatments with 0.1mT (a), 0.5mT (b), and 1.0mT (c). Data
are means ± SD from two independent experiments, each performed in six independent culture wells (𝑛 = 12).
myogenin, two earlymarkers ofmyogenesis.Themorpholog-
ical analysis was quantified according to the Fusion Index,
which was calculated as the percentage of C2C12 myoblasts
(of the total) that underwent the differentiation process. The
exposure to ELF-EMFs at the 0.5mT and 1.0mT intensities
induced significant acceleration of the first phases of themyo-
genic process. Indeed, the C2C12 myoblasts showed signifi-
cantly higher Fusion Index when exposed to ELF-EMF treat-
ments with 0.5mT after 2 days to 5 days and with 1.0mT after
2 days to 3 days (Figures 2(b) and 2(c)). No significant differ-
ences were observed for theC2C12myoblast cultures exposed
to ELF-EMFs at 0.1mT, in comparison with the untreated
controls (Figure 2(a)).
MyoD and myogenin expression levels showed some
increases for theC2C12myoblasts exposed to ELF-EMF treat-
ments, with respect to the corresponding control cells (Fig-
ure 3). For the ELF-EMF treatment with 0.1mT, this increase
was evident only for myogenin expression after 72 hours
of exposure. The exposure to 0.5mT intensity triggered an
increase of MyoD expression at 48 hours and of myogenin
expression at 24 and 48 hours. Differently, 1.0mT induced
increased MyoD expression at 24 hours and increased myo-
genin expression at 72 hours of exposure.
3.2. Influence of ELF-EMFs Treatments on C2C12 Myoblast
cx43 Expression and GJIC. The effects of ELF-EMF treat-
ments on differentiatingC2C12myoblasts were also evaluated
by an analysis of the efficiency of their gap-junction coupling
(dye-transfer efficiency) and by determining their expression
levels of cx43, the major gap-junction component in skeletal
myoblasts [20, 31, 32].
As illustrated by the representativeWestern blot and den-
sitometric analyses in Figure 4, during the ELF-EMF treat-
ment with 0.1mT, a transient, but not significant, increase in
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Figure 2: Effects of ELF-EMF treatments on the C2C12 myoblast myogenic process evaluated in the morphological analysis. Percentages
of differentiating C2C12 myoblasts expressed as the Fusion Index (see Materials and Methods), as quantified in C2C12 myoblast cultures
incubated in the absence (Ctr) and presence of ELF-EMF treatments with 0.1mT (a), 0.5mT (b), and 1.0mT (c). Data are means ± SEM from
two independent experiments, each performed in six independent culture wells (𝑛 = 12). ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001.
cx43 expression was seen only at 24 hours, with respect to the
corresponding control cells. Conversely, when the cells were
exposed to ELF-EMF treatment with 0.5mT, or 1.0mT, these
showed an increase in cx43 expression that became signifi-
cant at 72 hours, with respect to the corresponding control
cells (Figure 4).
The influence of the ELF-EMF treatment on C2C12 myo-
blast gap-junction function was tested using the microinjec-
tion/dye-transfer assay at the early stages of C2C12 myoblast
differentiation (i.e., 24, 48 h).These timeswere selected on the
basis that it is the earlier times that are crucial for the onset
of the differentiation program in these C2C12 myoblasts. In
addition, after 48 h, the high cell density that was reached
by the C2C12 myoblast monolayers made the single-cell
approach for the assay difficult. The quantitative analysis of
the extent of dye-coupling during the first 48 h of differentia-
tion of the C2C12myoblasts (e.g., see the representative phase
contrast and corresponding fluorescence images in panel (a)
and the graph in panel (b) of Figure 5) revealed an increased
number of coupled cells in the cultures exposed to ELF-EMF
treatment that became significant after 48 h at 1.0mT, in
comparison to the corresponding controls.
The treatment of the differentiatingC2C12myoblasts with
ELF-EMFs at 0.5 or 1.0mT increased not only the expression
of the major junction component, cx43, but also its assembly
into functional membrane channels, which allowed direct
cell-to-cell communication among the cells that were com-
mitted to differentiate.
4. Discussion
Epidemiological studies on the potential hazards of EMFs
for human health have generated many controversies and
attracted the attention of the media, the general public,
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Figure 3: Expression levels of MyoD and myogenin in differentiating C2C12 myoblasts during ELF-EMF treatments. ((a) and (c))
Representative immunoblot of MyoD and myogenin expression levels, respectively. ((b) and (d)) Densitometry analysis of MyoD and
myogenin expression levels, respectively, plotted as relative expression calculated by the ratio between OD × mm2 of MyoD or myogenin
band found in ELF-EMF-treated cells (0.1mT, 0.5mT, or 1.0mT) and OD × mm2 of the respective band in the corresponding control (Ctr).
Data are means ± SEM from three independent experiments. ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01 versus corresponding Ctr.
and biomedical researchers [33, 34]. On the other hand,
there is evidence of beneficial effects of magnetic fields and
EMFs in the treatment of various injuries and diseases [9].
Indeed, clinical benefits for EMFs have been claimed for 20
centuries, and even if there has been perplexity and medical
skepticism concerning their use, the application of EMFs
with a therapeutic aim is probably one of the most ancient
treatments used by Man [35].
Today, both static and time-varying magnetic fields are
applied therapeutically with success in the treatment of
musculoskeletal injuries or dysfunction [36]. There are also
a large number of experimental and clinical studies that have
demonstrated that various exogenous EMFs at surprisingly
low levels can have effects on a variety of biological systems
and processes, most of which are of critical importance for
diagnostics and therapy. Along with the evidence from in
vitro cellular models, clinical and preclinical studies have
suggested that magnetic field and EMF stimulation can
accelerate healing processes and influence nerve repair and
regeneration [7].
Skeletal muscle also represents a potential target for the
biological effect(s) of ELF-EMFs, and this property might be
of great importance, due in particular to their diffuse medical
applications in physical and rehabilitationmedicine. To better
clarify this point, the objective of the present study was to
investigate the effects of ELF-EMFs on the myogenic process.
To achieve this, the C2C12 myoblastic cell line was chosen
as a suitable in vitro model of skeletal muscle differentiation.
The use of a well-characterized experimentalmodel, the strict
control of the experimental procedures, and the optimization
of the protocol for this C2C12 myoblast exposure to ELF-
EMFs have provided us with improved understanding of the
cellular mechanism responsible for ELF-EMF-induced cell
modifications, which have remained largely unknown to date.
The data presented here demonstrate that under these
experimental conditions ELF-EMFs at 50Hz and with elec-
tromagnetic field strengths from 0.1 to 1.0mT do not affect
either C2C12myoblast viability or proliferation rate.This thus
initially demonstrates that there are no direct toxic effects
of ELF-EMFs on this cell model. Even if this finding is in
apparent contrast withwhat has been observedwith other cell
models, it is important to bear inmind that, in themany stud-
ies that have reported that ELF-EMFs can act on cell prolifer-
ation and cell-cycle progression, these effects have depended
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Figure 4: Expression levels of cx43 in differentiating C2C12 myo-
blasts during ELF-EMF treatments. (a) Representative immunoblot
of cx43 expression levels, from three independent experiments. (b)
Densitometry analyses plotted as relative expression calculated by
the ratio between OD ×mm2 of the cx43 band found in ELF-EMF-
treated cells (0.1mT, 0.5mT, and 1.0mT), and OD × mm2 of the
respective band in the corresponding control (Ctr). Data are means
± SEM from three independent experiments ∗∗𝑝 < 0.01 versus
corresponding Ctr.
on the cell phenotype, as well as on the intensity, frequency,
and wave form of ELF-EMFs applied, and length of the
exposure [37–42].
In recent decades, a large amount of evidence has demon-
strated prodifferentiating effects of ELF-EMFs on different
cell phenotypes, and interesting data have also been obtained
using adult stem cells, with the suggestion that ELF-EMFs
represent an efficacious therapeutic approach [28, 39, 43–45].
On the other hand, the mechanism(s) of action of ELF-EMFs
on physiological processes and their intracellular molecular
targets are far from being defined. In the cell model in
the present study, the presence of ELF-EMFs enhanced the
myogenic process. This process progresses through a highly
ordered sequence of events, includingmorphological changes
(i.e., cell alignment, fusion) and specific time-courses of gene
expression patterns [46]. In addition, published data have
strongly supported a key role for GJIC in the first phase of
myogenic differentiation, whenmyoblasts that are committed
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Figure 5: Functional coupling in differentiating C2C12 myoblasts
during ELF-EMF treatments. (a) Representative phase contrast and
corresponding fluorescence images of the C2C12 myoblasts in the
absence (Ctr) and presence of ELF-EMF treatment with 1.0mT,
from the beginning of the differentiation process (𝑇0, time 0) and
after 24 h and 48 h in differentiation medium. Scale bars, 50 𝜇m. (b)
Quantification of dye-coupled cells under the conditions described
in (a). Data are means ± SEM from two independent experiments,
each performed with at least 10 independent microinjections/plate.
∗𝑝 < 0.05 versus corresponding Ctr.
to differentiate then adhere and fuse, to form gap junctions.
These gap junctions then allow the intercellular diffusion of
critical signals, such as Ca2+, inositol 1,4,5-trisphosphate, and
adenosine 5󸀠-triphosphate [24]. Indeed, when blockers of the
permeability of these junction channels are used, or in the
presence of inducible deletion of cx43, downregulation of
myogenic factors is seen [21–23, 47]. Furthermore, transfec-
tion of rhabdomyosarcoma cells with cx43 cDNA was shown
to induce cell differentiation [48]. In particular, in myoblasts,
cx43 expression is predominant, and it is a prerequisite for
their fusion [32]. Indeed, cx43 gap-junction channels have
been shown to provide the intercellular signaling pathways
that are required for normal timing of skeletal muscle ontog-
eny and regeneration [20]. In our cell model, ELF-EMFs at
0.1mT only transiently affected cx43 expression but at 0.5mT
and 1.0mT modified GJIC activity through increases in both
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the expression of the cx43 protein and cell coupling in cul-
tures committed to differentiate. These data are complemen-
tary to our previous report regarding the evidence that ELF-
EMFs can affect the Ca2+ handling and redox status of C2C12
myoblasts [10].These processes are responsible for the pheno-
typic cell reactions to environmental stimuli, and they might
provide the means through which ELF-EMFs can accelerate
themyogenesis process through increased extent of the GJIC,
as the regulation of Ca2+ fluxes by gap junctions and their
response to oxidative stress have been well demonstrated
[49].
5. Conclusions
In conclusion, although our data do not show clear dose-
dependence or threshold-induced effects, ELF-EMFs in the
mT intensity range accelerated the myogenic process in these
C2C12 myoblasts. In the same cell model, ELF-EMFs can
affect the cellular redox state and intracellular Ca2+ dynamics
[10] and, consequently, cell metabolic activity. All of these
events can be proposed as key triggers involved in increases
in specificmyogenicmarkers (e.g.,MyoD andmyogenin) and
the promotion of cell fusion, which is made more efficient by
the increased GJIC activity, all of which are steps that can be
enhanced by ELF-EMFs.
Taken together, all these evidences indicate for the first
time the mechanism of action through which ELF-EMFs can
promote skeletal muscle differentiation. This thus provides
a scientific basis to what is considered an efficacious thera-
peutic means to resolve, at least in part, some conditions of
muscle dysfunction.
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